Aeglea BioTherapeutics (NASDAQ:AGLE) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) in a report released on Tuesday. The brokerage issued a hold rating on the biotechnology company’s stock. Other analysts have also recently issued reports about the stock. Jonestrading reiterated a hold rating on shares of Aeglea BioTherapeutics in a research note on Wednesday, […]

Related Keywords

Aeglea Biotherapeutics ,Ghost Tree Capital ,Aeglea Biotherapeutics Company Profile ,Wells Fargo Company ,Aeglea Biotherapeutics Inc ,Goldman Sachs Group Inc ,Acadian Asset Management ,Charles Schwab Investment Management Inc ,Get Rating ,Wells Fargo ,Schwab Investment Management ,Asset Management ,Street Corp ,Sachs Group ,Tree Capital ,